Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: An individual participant data meta-analysis of atezolizumab clinical trials: Smoking and immunotherapy efficacy in lung cancer

Eur J Cancer. 2022 Jan:160:279-281. doi: 10.1016/j.ejca.2021.10.020. Epub 2021 Nov 30.
No abstract available

Keywords: Atezolizumab; Non-small cell lung cancer; Smoking.

Publication types

  • Letter
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / pharmacology
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Immunotherapy / methods*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / etiology*
  • Lung Neoplasms / pathology
  • Smoking / adverse effects*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • atezolizumab